(19)
(11) EP 4 739 700 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24840339.6

(22) Date of filing: 05.07.2024
(51) International Patent Classification (IPC): 
C07K 14/135(2006.01)
A61K 39/12(2006.01)
C12N 15/86(2006.01)
A61K 38/16(2006.01)
A61P 31/14(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 39/12; A61P 31/14; C07K 14/005; C12N 2760/18534; C12N 2760/18522; C12N 2760/18523; A61K 2039/54; A61K 2039/545; A61K 2039/70; A61K 38/00
(86) International application number:
PCT/US2024/036932
(87) International publication number:
WO 2025/014822 (16.01.2025 Gazette 2025/03)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 07.07.2023 US 202363525447 P

(71) Applicants:
  • Emory University
    Atlanta, Georgia 30322 (US)
  • Children's Healthcare of Atlanta, Inc.
    Atlanta, GA 30329 (US)

(72) Inventors:
  • ANDERSON, Larry James
    Atlanta, Georgia 30322 (US)
  • HA, Binh
    Atlanta, Georgia 30322 (US)
  • SUN, Heying
    Atlanta, Georgia 30322 (US)

(74) Representative: Duncombe, Jessica et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) RESPIRATORY SYNCYTIAL VIRUS MUTANTS, FUSION PEPTIDES, PARTICLES, NUCLEIC ACIDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE